Cvs Health (And Subsidiaries)
lobbying client · lobbying firm
Cvs Health (And Subsidiaries)'s federal footprint — reported lobbying spend and, where matched, federal money received. Figures are as reported to the U.S. Senate (LDA) and USAspending.
Reported country: 🇺🇸 United States
Lobbying over time
| FY | Lobbying spend (as client) | Lobbying billed / handled (as firm) |
|---|---|---|
| 2022 | $11,000,000 | $10,550,000 |
| 2023 | $12,070,000 | $11,750,000 |
| 2024 | $9,440,000 | $9,240,000 |
| 2025 | $10,090,000 | $9,690,000 |
Two figures: what Cvs Health (And Subsidiaries) reported spending on its own lobbying (as a client) and what it billed or handled for the clients it represents (as a firm — revenue, not its own spend). For a self-filer these overlap.
Firms hired
- Alb Solutions $790,000 · 16 filings
- Fulcrum Public Affairs LLC $380,000 · 6 filings
- Thegroup Dc, LLC $200,000 · 4 filings
Registrants that filed lobbying on behalf of Cvs Health (And Subsidiaries).
Clients represented
Self-filed — Cvs Health (And Subsidiaries) registers and lobbies on its own behalf, with no separate outside clients.
Issues
| Issue area | Lobbied | Worked |
|---|---|---|
| Health Issues | 27 | — |
| Pharmacy | 20 | 16 |
| Medicare/Medicaid | 17 | 16 |
| Consumer Issues/Safety/Products | 16 | 16 |
| Insurance | 16 | 16 |
| Labor Issues/Antitrust/Workplace | 16 | 16 |
| Taxation/Internal Revenue Code | 16 | 16 |
| Advertising | 3 | 3 |
| Postal | 2 | 2 |
Issue areas across Cvs Health (And Subsidiaries)'s filings, by activity count — as the client (Lobbied) and as the registrant/firm (Worked). Linked areas open the CivicGate issue page.
What they lobbied on
Reported activity from Senate LDA
-
FY2025 Health Issues as client
Tracked issues related to pharmacy services, Medicare Advantage and other health issues
-
FY2025 Pharmacy as client
Tracked issues related to pharmacy services and other health issues.
-
FY2025 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health.
-
FY2025 Taxation/Internal Revenue Code self-filed
Issues related to corporate tax.
-
FY2025 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 882, the Patients Before Middlemen (PBM) Act S. 927, the Protecting Pharmacies in Medicaid Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034
-
FY2025 Insurance self-filed
Issues related to employer, small group and individual insurance markets. S. 864, the Help Ensure Lower Patients (HELP) Copays Act H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act
-
FY2025 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.
-
FY2025 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime.
Show 52 more activities
-
FY2025 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act
-
FY2025 Taxation/Internal Revenue Code self-filed
Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act
-
FY2025 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act S. 3345, The PBM Price Transparency and Accountability Act H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act H.R. 4093, Apple to Apples Comparison Act H.R. 6575, CommonGround for Affordable Health Care Act H.R. 6703, The Lower Healthcare Premiums for All Americans Act H.R.6609, The Pharmacists Fight Back in Medicare and Medicaid Act
S. 882 S. 927 S. 1105 S. 3345 H.R. 4317 H.R. 4093 H.R. 6575 H.R. 6703 H.R. 6609
-
FY2025 Insurance self-filed
Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back in Federal Health Benefits Plan Act
-
FY2025 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. S. 2099, The Restore Prescription Drugs Discount Act
-
FY2025 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act
-
FY2025 Advertising self-filed
S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025
-
FY2025 Medicare/Medicaid as client
Tracked issues related to pharmacy services, Medicare Advantage and other health issues
-
FY2025 Health Issues as client
Health care policy issues.
-
FY2025 Health Issues as client
Health care policy issues.
-
FY2025 Health Issues as client
Health care policy issues.
-
FY2025 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy
-
FY2025 Taxation/Internal Revenue Code self-filed
Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act
-
FY2025 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs
-
FY2025 Insurance self-filed
Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act
-
FY2025 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act
-
FY2025 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act
-
FY2025 Advertising self-filed
S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025
-
FY2025 Health Issues as client
Tracked issues related to pharmacy services and other health issues
-
FY2025 Pharmacy as client
Tracked issues related to pharmacy services and other health issues
-
FY2025 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy
-
FY2025 Taxation/Internal Revenue Code self-filed
Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act
-
FY2025 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act
-
FY2025 Insurance self-filed
Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025
-
FY2025 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act S. 2099, The Restore Prescription Drugs Discount Act
-
FY2025 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act
-
FY2025 Advertising self-filed
S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025
-
FY2025 Health Issues as client
Issues related to pharmacy services and other health issues.
-
FY2025 Pharmacy as client
Issues related to pharmacy services and other health issues.
-
FY2025 Health Issues as client
Tracked issues related to pharmacy services, Medicare Advantage and other health issues
-
FY2025 Pharmacy as client
Tracked issues related to pharmacy services and other health issues.
-
FY2025 Health Issues as client
Health care policy issues.
-
FY2024 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act
H.R. 1770 S. 2477
-
FY2024 Taxation/Internal Revenue Code self-filed
Issues related to the corporate tax rate.
-
FY2024 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act H.R. 2880 - Protecting Patients Against PBM Abuses Act
S. 1339 S. 1967 S. 2973 S. 3430 H.R. 2679 H.R. 3285 H.R. 1613 H.R. 3561 H.R. 5378 H.R. 2880
-
FY2024 Insurance self-filed
Issues related to employer, small group and individual insurance markets. S. 1542/H.R. 6283 - Delinking Revenue from Unfair Gouging Act
S. 1542 H.R. 6283
-
FY2024 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.
-
FY2024 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime and consumer safety.
-
FY2024 Pharmacy self-filed
Issues related to retail pharmacy, drug pricing, and women's health. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act
H.R. 1770 S. 2477
-
FY2024 Taxation/Internal Revenue Code self-filed
Issues related to the corporate tax rate.
-
FY2024 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act H.R. 2880 - Protecting Patients Against PBM Abuses Act
S. 1339 S. 1967 S. 2973 S. 3430 H.R. 2679 H.R. 3285 H.R. 1613 H.R. 3561 H.R. 5378 H.R. 2880
-
FY2024 Insurance self-filed
Issues related to employer, small group and individual insurance markets. S. 1542/H.R. 6283 - Delinking Revenue from Unfair Gouging Act
S. 1542 H.R. 6283
-
FY2024 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.
-
FY2024 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime and consumer safety.
-
FY2024 Health Issues as client
Health care policy issues.
-
FY2024 Pharmacy self-filed
Issues related to drug pricing transparency, women's health, and COVID-19 testing, vaccination and treatment. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act
H.R. 1770 S. 2477
-
FY2024 Taxation/Internal Revenue Code self-filed
Issues related to the corporate tax rate.
-
FY2024 Insurance self-filed
Issues related to employer, small group and individual insurance markets. H.R. 6283 - Delinking Revenue from Unfair Gouging Act
H.R. 6283
-
FY2024 Labor Issues/Antitrust/Workplace self-filed
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.
-
FY2024 Consumer Issues/Safety/Products self-filed
Issues related to organized retail crime and consumer safety.
-
FY2024 Medicare/Medicaid self-filed
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act H.R. 2880 - Protecting Patients Against PBM Abuses Act
S. 1339 S. 1967 S. 2973 S. 3430 H.R. 2679 H.R. 3285 H.R. 1613 H.R. 3561 H.R. 5378 H.R. 2880
-
FY2024 Health Issues as client
Health care policy issues.
The specific issues and bills Cvs Health (And Subsidiaries) reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.